Tag: Canopy growth stock price

On November 15, MedMen (MMEN) (MMNFF) declared an extensive five-year restructuring plan in its attempt to become EBITDA-positive by 2020.

Canopy Growth reported its second-quarter earnings results today. It's already down 16.07% on the day and is trading at 20.52 Canadian dollars on the TSE.

As noted by MKM Partners, yesterday Aurora Cannabis (ACB) fell by 4.97% and closed at $4.78 Canadian dollars. Also, Canopy Growth (CGC) fell by 5.19%

MedMen's disappointing fourth-quarter results caused the stock price to fall. The company missed analysts' revenue estimates for the quarter.

Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.

Canopy Growth (CGC) (WEED) and Cronos Group (CRON) are set to release their earnings next week. The cannabis sector has been on a roller coaster this year.

Canopy Growth (CGC), Aurora Cannabis (ACB), and Cronos Group (CRON) closed at year-to-date discounts of 33.43%, 32.97%, and 30%, respectively, yesterday.

On October 30, Wisconsin lawmakers introduced a bill to decriminalize marijuana possession. Here are five things to know about Wisconsin and legalization.

So far, Charlotte’s Web Holdings (CWBHF) (CWEB) has gained 19.7% year-to-date. The company will report its third-quarter results next month.

Cannabis legalization is approaching the deadline in Mexico. According to the Supreme Court, the deadline for marijuana legalization is Wednesday.